191 related articles for article (PubMed ID: 27927689)
1. S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer.
Ismail TM; Bennett D; Platt-Higgins AM; Al-Medhity M; Barraclough R; Rudland PS
Cancer Res; 2017 Feb; 77(3):780-789. PubMed ID: 27927689
[TBL] [Abstract][Full Text] [Related]
2. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
3. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
4. S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity.
Zhang HY; Zheng XZ; Wang XH; Xuan XY; Wang F; Li SS
Mol Biol Rep; 2012 Jan; 39(1):199-208. PubMed ID: 21603862
[TBL] [Abstract][Full Text] [Related]
5. S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2.
Xu H; Li M; Zhou Y; Wang F; Li X; Wang L; Fan Q
Tumour Biol; 2016 Mar; 37(3):2925-32. PubMed ID: 26409452
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
[TBL] [Abstract][Full Text] [Related]
7. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
8. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
9. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.
Fabris L; Cadamuro M; Moserle L; Dziura J; Cong X; Sambado L; Nardo G; Sonzogni A; Colledan M; Furlanetto A; Bassi N; Massani M; Cillo U; Mescoli C; Indraccolo S; Rugge M; Okolicsanyi L; Strazzabosco M
Hepatology; 2011 Sep; 54(3):890-9. PubMed ID: 21618579
[TBL] [Abstract][Full Text] [Related]
11. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.
Stewart RL; Carpenter BL; West DS; Knifley T; Liu L; Wang C; Weiss HL; Gal TS; Durbin EB; Arnold SM; O'Connor KL; Chen M
Oncotarget; 2016 Jun; 7(23):34630-42. PubMed ID: 27127879
[TBL] [Abstract][Full Text] [Related]
12. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
[TBL] [Abstract][Full Text] [Related]
13. IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9.
Huang Q; Lan F; Wang X; Yu Y; Ouyang X; Zheng F; Han J; Lin Y; Xie Y; Xie F; Liu W; Yang X; Wang H; Dong L; Wang L; Tan J
Mol Cancer; 2014 Jan; 13():18. PubMed ID: 24479681
[TBL] [Abstract][Full Text] [Related]
14. S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is associated with the "MELF" pattern.
Tahara S; Nojima S; Ohshima K; Hori Y; Kurashige M; Wada N; Ikeda J; Morii E
Cancer Sci; 2016 Sep; 107(9):1345-52. PubMed ID: 27348205
[TBL] [Abstract][Full Text] [Related]
15. Activation of metalloproteinases-2 and -9 by interleukin-1alpha in S100A4-positive liposarcoma cell line: correlation with cell invasiveness.
Pazzaglia L; Ponticelli F; Magagnoli G; Magagnoli G; Gamberi G; Ragazzini P; Balladelli A; Picci P; Benassi M
Anticancer Res; 2004; 24(2B):967-72. PubMed ID: 15161051
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.
Cadamuro M; Spagnuolo G; Sambado L; Indraccolo S; Nardo G; Rosato A; Brivio S; Caslini C; Stecca T; Massani M; Bassi N; Novelli E; Spirli C; Fabris L; Strazzabosco M
Cancer Res; 2016 Aug; 76(16):4775-84. PubMed ID: 27328733
[TBL] [Abstract][Full Text] [Related]
17. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
[TBL] [Abstract][Full Text] [Related]
18. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.
Huang L; Xu Y; Cai G; Guan Z; Cai S
Oncol Rep; 2012 Apr; 27(4):917-22. PubMed ID: 22200787
[TBL] [Abstract][Full Text] [Related]
20. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
